294 related articles for article (PubMed ID: 24430184)
1. Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.
Li H; Tan M; Jia L; Wei D; Zhao Y; Chen G; Xu J; Zhao L; Thomas D; Beer DG; Sun Y
J Clin Invest; 2014 Feb; 124(2):835-46. PubMed ID: 24430184
[TBL] [Abstract][Full Text] [Related]
2. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Sag/Rbx2/Roc2 e3 ubiquitin ligase triggers senescence and inhibits kras-induced immortalization.
Tan M; Li H; Sun Y
Neoplasia; 2015 Jan; 17(1):114-23. PubMed ID: 25622904
[TBL] [Abstract][Full Text] [Related]
4. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis.
Xie CM; Wei D; Zhao L; Marchetto S; Mei L; Borg JP; Sun Y
J Cell Biol; 2015 Jun; 209(5):721-37. PubMed ID: 26056141
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid.
Tan M; Li Y; Yang R; Xi N; Sun Y
PLoS One; 2011; 6(11):e27726. PubMed ID: 22110742
[TBL] [Abstract][Full Text] [Related]
6. Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target.
Jia L; Yang J; Hao X; Zheng M; He H; Xiong X; Xu L; Sun Y
Clin Cancer Res; 2010 Feb; 16(3):814-24. PubMed ID: 20103673
[TBL] [Abstract][Full Text] [Related]
7. Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.
Tan M; Li H; Sun Y
Oncogene; 2014 Oct; 33(44):5211-20. PubMed ID: 24213570
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.
Sun Y; Li H
Protein Cell; 2013 Feb; 4(2):103-16. PubMed ID: 23136067
[TBL] [Abstract][Full Text] [Related]
9. The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model.
Tan M; Chang Y; Liu X; Li H; Tang Z; Nyati MK; Sun Y
Cell Rep; 2022 Dec; 41(12):111837. PubMed ID: 36543126
[TBL] [Abstract][Full Text] [Related]
10. Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC model.
Zhang Q; Wei D; Tan M; Li H; Morgan MA; Sun Y
Neoplasia; 2020 Apr; 22(6):242-252. PubMed ID: 32339950
[TBL] [Abstract][Full Text] [Related]
11. SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation.
Kuang P; Tan M; Zhou W; Zhang Q; Sun Y
Sci Rep; 2016 Dec; 6():37441. PubMed ID: 27910872
[TBL] [Abstract][Full Text] [Related]
12. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
Gu Q; Tan M; Sun Y
Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
[TBL] [Abstract][Full Text] [Related]
13. SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.
Tan M; Zhao Y; Kim SJ; Liu M; Jia L; Saunders TL; Zhu Y; Sun Y
Dev Cell; 2011 Dec; 21(6):1062-76. PubMed ID: 22118770
[TBL] [Abstract][Full Text] [Related]
14. Neddylation E2 UBE2F Promotes the Survival of Lung Cancer Cells by Activating CRL5 to Degrade NOXA via the K11 Linkage.
Zhou W; Xu J; Li H; Xu M; Chen ZJ; Wei W; Pan Z; Sun Y
Clin Cancer Res; 2017 Feb; 23(4):1104-1116. PubMed ID: 27591266
[No Abstract] [Full Text] [Related]
15. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.
Gu Q; Bowden GT; Normolle D; Sun Y
J Cell Biol; 2007 Sep; 178(6):1009-23. PubMed ID: 17846172
[TBL] [Abstract][Full Text] [Related]
16. Advancements and perspectives of RBX2 as a molecular hallmark in cancer.
Tao Y; Dai L; Liang W; Li X; Lyu Y; Li J; Li Z; Shi Z; Liang X; Zhou S; Fu X; Hu W; Wang X
Gene; 2024 Jan; 892():147864. PubMed ID: 37820940
[TBL] [Abstract][Full Text] [Related]
17. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
18. Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulation.
Duan H; Tsvetkov LM; Liu Y; Song Y; Swaroop M; Wen R; Kung HF; Zhang H; Sun Y
Mol Carcinog; 2001 Jan; 30(1):37-46. PubMed ID: 11255262
[TBL] [Abstract][Full Text] [Related]
19. SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.
Tan M; Gallegos JR; Gu Q; Huang Y; Li J; Jin Y; Lu H; Sun Y
Neoplasia; 2006 Dec; 8(12):1042-54. PubMed ID: 17217622
[TBL] [Abstract][Full Text] [Related]
20. Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets.
Wei D; Sun Y
Genes Cancer; 2010 Jul; 1(7):700-7. PubMed ID: 21103004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
